Navigation Links
KCNQ2 Cure Alliance Extends Collaboration With Pairnomix To Provide Genetic Evaluation Services For Patients With Rare Genetic Epileptic Encephalopathy
Date:7/20/2017

DENVER and PLYMOUTH, Minn., July 20, 2017 /PRNewswire/ -- KCNQ2 Cure Alliance and Pairnomix, LLC, a personalized genetic evaluations company, today announced that they have completed the first case under their partnership investigating a genetic mutation implicated in KCNQ2 epileptic encephalopathy. They also report plans to extend the partnership for a second case involving an additional KCNQ2 genetic mutation.

Last year, the KCNQ2 Cure Alliance and Pairnomix entered into a collaboration to further explore genetic mutations in KCNQ2 epileptic encephalopathy with the goal of identifying more effective and more accurately targeted drug therapies. It is estimated that 500 people worldwide have been diagnosed with KCNQ2 epileptic encephalopathy. However, many more are believed to be affected by this rare genetic mutation, but have not been diagnosed due to its relatively recent discovery and availability of genetic testing.

At the end of this first case evaluation, Pairnomix identified through cellular testing a series of drugs capable of inhibiting a gain-of-function KCNQ2 mutation. These drugs represent novel therapeutic options for the consideration of healthcare providers.

"We appreciate the thorough approach Pairnomix undertook while evaluating our first case together and we are excited to see the real-world application from this data," said Jim Johnson, President of KCNQ2 Cure Alliance.

"The KCNQ2 Cure Alliance is a truly caring and supportive organization. We feel privileged to provide our services in an effort to support their community," said Matthew Fox, CEO of Pairnomix.

Clinical evaluation of the top drug result is currently underway and the genetic evaluation of the second case has recently been initiated. Pairnomix and the KCNQ2 Cure Alliance will present data from the initial case at scientific conferences later this year including the annual meetings for Child Neurology Society (CNS), Society for Neuroscience (SfN), and American Epilepsy Society (AES).

About KCNQ2 Epileptic Encephalopathy
KCNQ2 epileptic encephalopathies are caused by mutations in the KCNQ2 gene (also known as the potassium voltage-gated channel, KQT-like subfamily, member 2 gene). KCNQ2 belongs to a large family of genes that provide instructions for making potassium channels. These channels, which transport positively charged atoms (ions) of potassium into and out of cells, play a key role in a cell's ability to generate and transmit electrical signals. Channels made with the KCNQ2 protein are active in nerve cells (neurons) in the brain, where they transport potassium ions out of cells.

About Pairnomix
Pairnomix™, a personalized genetic evaluations company, is committed to helping people living with rare diseases understand the genetic cause of their condition and explore potential treatment options that are available today. Pairnomix' initial focus is on advancing personalized research for people living with epilepsy and other disorders of the Central Nervous System. To learn more, please visit www.pairnomix.com.

 

View original content with multimedia:http://www.prnewswire.com/news-releases/kcnq2-cure-alliance-extends-collaboration-with-pairnomix-to-provide-genetic-evaluation-services-for-patients-with-rare-genetic-epileptic-encephalopathy-300491333.html


'/>"/>
SOURCE Pairnomix, LLC
Copyright©2017 PR Newswire.
All rights reserved


Related biology technology :

1. Asymmetrex Presents Adult Tissue Stem Cell Counting at the Alliance for Regenerative Medicine’s First Partnering Conference, May 22-23
2. Enzo Biochem Partnering Deals and Alliances 2010 to 2017
3. University of Pittsburgh and Bayer Form Alliance to Advance Research for New Therapies for Heart, Lung and Blood Diseases
4. Inflamax Research Expands to the EU in Strategic Alliance with the Vienna Challenge Chamber
5. Massachusetts General Hospital Enters Into a Technology Alliance Partnership with IntelliCyt for the Development of CRISPR Functional Screening Applications
6. QIAGEN Forms Lung Cancer Expert Alliance
7. Global Stem Cells Group and Kimera Labs Announce Autologous Stem Cell Research Alliance
8. Interventional Concepts and ACRES Announce Alliance for Colombia
9. Aptuit et Icagen concluent une alliance stratégique
10. WuXi and AstraZeneca Form Strategic Alliance to Expedite Development of AstraZenecas Innovative Biologics Portfolio in China
11. HUYA Bioscience International Announces A Strategic Alliance With The Korea Drug Development Fund
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... ... innovation and business process optimization firm for the life sciences and healthcare industries, ... conference in San Francisco. , The presentation, “Automating GxP Validation for Agile ...
(Date:10/9/2017)... ... ... At its national board meeting in North Carolina, ARCS® Foundation ... Physics and Astronomy, has been selected for membership in ARCS Alumni Hall of ... Breakthrough Prize in Fundamental physics for the discovery of the accelerating expansion of the ...
(Date:10/7/2017)... Seattle, WA (PRWEB) , ... ... ... the industry leader in Hi-C-based genomic technologies, launched its ProxiMeta™ Hi-C metagenome ... the ProxiMeta Hi-C kit and accompanying cloud-based bioinformatics software to perform Hi-C ...
(Date:10/5/2017)... , ... October 05, 2017 , ... LabRoots , ... scientists from around the world, is giving back to cancer research with a month-long ... , Now through October 31, shoppers can use promo code PinkRibbon to get ...
Breaking Biology Technology:
(Date:8/15/2017)...   ivWatch LLC , a medical device company focused on ... receipt of its ISO 13485 Certification, the global standard for medical ... Standardization (ISO®). ... Continuous Monitoring device for the early detection of IV infiltrations. ... "This is an important milestone for ivWatch, as ...
(Date:5/23/2017)... , May 23, 2017  Hunova, the first robotic gym for the ... been officially launched in Genoa, Italy . The first ... and the USA . The technology was developed ... market by the IIT spin-off Movendo Technology thanks to a 10 million ... News Release, please click: ...
(Date:4/19/2017)... , April 19, 2017 The ... vendor landscape is marked by the presence of several ... however held by five major players - 3M Cogent, ... companies accounted for nearly 61% of the global military ... companies in the global military biometrics market boast global ...
Breaking Biology News(10 mins):